Study Of 323U66 SR In Major Depressive Disorder

Clinical trial NCT00135512 · COMPLETED

Trial details

NCT number: NCT00135512
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2004-12-01
Primary completion: 2007-05-28
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.